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Abstracts / Urological Science 26 (2015) S50eS81S70Purpose: In upper urinary tract (UUT), squamous cell carcinoma (SCC) and
urothelial carcinoma (UC) are two different disease in its etiology, inci-
dence and prognosis. Due to paucity of the study in SCC, we treat it just as
UC. However, we believe the therapeutic and following protocols for the
two diseases are different. In this study, we compare the bladder recur-
rence rate in these two malignancies.
Materials and Methods: From January 2000 to December 2007, 327 pa-
tients were diagnosed as upper urinary tract malignancy. Their clinical and
pathological characteristics were retrospectively reviewed. There were
294 pure UC (90.0%), 24 UCwith squamous differentiation (SqD) (7.3%) and
9 pure SCC (2.7%) patient. These patients all received RNU initially. Kaplan-
Meier method was used to estimate bladder recurrence free survival (RFS).
The recurrence curve is compared by log rank test. The statistical signiﬁ-
cance was set as p&0.05.
Results: The 5-year RFSs of bladder were 67.9%, 70.4 and 100% in UC, UC
with SqD and SCC groups respectively. Pairwise comparisonwas done., and
here was no signiﬁcant difference in bladder RFS between two groups. The
p-value of log-rank test comparing UC and SCC is 0.061. Although not
statistically signiﬁcant, there was a trend that patients with UUT-SCC had
less bladder recurrence after initially operative management.
Conclusion: There was a statistical trend that patients with UUT-SCC had
less bladder recurrence after initially operative management. It did not
reach signiﬁcance because of the small number of patients with SCC.
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Purpose: To compare the observed androgen-dependent prostate cancer
cells (LNCaP), transformed into a differential expression of androgen-in-
dependent prostate cancer cells (LNCaP -androgen independent) process
microRNA explore highmicroRNA expression differences in the conversion
process regulatory mechanisms may play its target genes.
Materials andMethods: LNCaP, anti-androgen drugs (high expression and
low expression for 3 months LNCaP and LNCaP -androgen independent
transformed into microRNA expression between cells, choose large dif-
ferences in the use of Agilent to validate, and bioinformatics analysis,
looking for differences in the expression of microRNA target gene. Lucif-
erase reporter assay to demonstrate the use of the target gene does. This
will take advantage of siRNA way to suppress or to increase the perfor-
mance of high performance differences of microRNA, microRNA to conﬁrm
the high performance difference does affect the formation of androgen-
independent prostate cancer cells
Results: Under the gene chip can get more than 100 have differences in
microRNA, but we only pick the difference more than 10 times higher
than the microRNA analysis to identify prostate cancer cells are most
likely to affect the transition from androgen-dependent a non-androgen
dependent microRNA. We found miR-221 is the highest performance
microRNA.
Conclusion: The miR-221 is one of the highest performance difference
does affect the formation of androgen-independent prostate cancer cells.
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Purpose: Wilms' tumor (nephroblastoma) is the most common solid pri-
mary renal malignancy in children but extremely rare in adult population.We present single institution experience of adult Wilms' tumor in order to
assess the clinical characteristics, radiological features, and surgical
prognosis.
Materials and Methods: A retrospective review was carried out to
investigate the patients with adultWilms' tumor at the Tri-Service General
Hospital during a 45-year period (1970 - 2014). Seven patientsS 16 years
old (one female and six male; median age at the time of diagnosis of 24
years; range 24 - 48 years) were staged according to the National Wilms'
Tumor Study (NWTS) staging system as follows: 3 patients had stage II
disease, 2 patients had stage III disease and 2 patients had stage IV disease
Results: The most common presentation is ﬂank pain (57%) followed by
palpable mass (43 %). Only one patient presented with gross hematuria.
Four patients underwent renal arteriography which all disclosed irregular,
tortuous vessel pattern with faint tumor stain. All patients underwent
radical nephrectomy (one hand-assisted laparoscopic nephrectomy and 6
open transperitoneal nephrectomy). Two patients developed lung metas-
tases after radical surgery. All but one patient received multimodal ther-
apy, including surgery, chemotherapy and radiation therapy. The mean
disease-free survival is 81months. Three-year and ﬁve-year survival rate is
60 % and 50 % separately.
Conclusion: Selective renal arteriography provides valuable diagnostic
hint in adult Wilms' tumor. Using multimodality therapy, improved
prognosis could be achieved.
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Purpose: To determine the efﬁcacy of switching therapy with a second
LHRH analogue after PSA progression for advanced prostate cancer.
Materials and Methods: Between December 2005 to September 2013,
there were 200 patients with nodal positive, metastatic prostate cancer
or disease progression after deﬁnite treatment receiving continuous
LHRH analogues therapy with monthly Depot leuprorelin (sc)
acetate 3.75mg/vial (LA) or Gorserelin acetate (sc) 3.6mg /vial (GA). If
the patients had castration resistant prostate cancer, the treatment
choice of switching therapy (LA to GA or GA to LA) before entering
chemotherapy was given.The LH, testosterone level and PSA change
were recorded.
Results: 127 patients receiving LA as initial ADT therapy and the other
73 patients were in GA therapy. A total of 92 patients (54 patients got
LA to GA and 38 got GA to LA) got LHRH analogue switching therapy.
The effect of LH and testosterone reducing before and after switching
therapy was comparable between two groups and the increasing PSA
level after three-months treatment was seen in both groups (median
PSA: 15.7 to 67.7ng/ml in LA to GA group and 15.2 to 71.4ng/ml in GA to
LA group).
Conclusion: Switching therapy for patients with PSA progression after
ADT has no efﬁcacy of further PSA decrease.
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Purpose: Several scoring system have been proposed to quantify surgical
complexity, and provide insight into expected perioperative and post-
operative surgical outcomes following partial nephrectomy. However, it is
still unclear that which of the scoring system has better outcome in pre-
dicting functional outcome after partial nephrectomy. In the present
study, we assess the use of R.E.N.A.L., PADUA and centrality index scores
to predict the renal function for patients who underwent partial
nephrectomy.
